AnnetteCReboliMD

PubMed

• 2 citations
  Cooper Medical School of Rowan University.
  Susan M. Perlis, Rose Kim, Annette C. Reboli> ;Academic Medicine. 2020 Sep 1
• 21 citations
  Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial
  Kathleen M. Mullane, Vicki A. Morrison, Luis H. Camacho, Ann M. Arvin, Shelly A. McNeil, Jessie Durrand, Bernadette Campbell, Shu-Chih Su, Ivan S. F. Chan, Janie Parri...> ;The Lancet. Infectious Diseases. 2019 Aug 6
• 104 citations
  Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel
  Cornelius J. Clancy, Peter G. Pappas, Jose A. Vazquez, Marc A. Judson, Dimitrios P. Kontoyiannis, George Richard Thompson, Kevin W. Garey, Annette C. Reboli, Richard N...> ;Clinical Infectious Diseases. 2018 May 17
• 14 citations
  Roadmap for creating an accelerated three-year medical education program.
  Shou Ling Leong, Joan Cangiarella, Tonya L. Fancher, Lisa Dodson, Colleen O'Connor Grochowski, Vicky Harnik, Carol Hustedde, Betsy Goebel Jones, Christina Kelly, Allis...> ;Medical Education Online. 2017 Nov 8
• 7 citations
  Assessing the Learning Environment for Medical Students: An Evaluation of a Novel Survey Instrument in Four Medical Schools.
  Linda H. Pololi, Arthur T. Evans, Leslie A. Nickell, Annette C. Reboli, Lisa D. Coplit, Margaret L. Stuber, Vasilia Vasiliou, Janet T. Civian, Robert T. Brennan> ;Academic Psychiatry. 2017 Jun 1
• 863 citations
  Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
  Peter G. Pappas, Carol A. Kauffman, David R. Andes, Cornelius J. Clancy, Kieren A. Marr, Luis Ostrosky-Zeichner, Annette C. Reboli, Mindy G. Schuster, Jose A. Vazquez,...> ;Clinical Infectious Diseases. 2016 Feb 15
• 22 citations
  Incidence and mortality of sepsis, severe sepsis, and septic shock in intensive care unit patients with candidemia.
  Kevin Ng, Christa A. Schorr, Annette C. Reboli, Sergio Zanotti, Constantine Tsigrelis> ;Infectious Diseases. 2015 Jul 7
• 276 citations
  Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registr...
  Michael A. Pfaller, David R. Andes, Daniel J. Diekema, David Horn, Annette C. Reboli, Coleman Rotstein, Billy Franks, Nkechi Azie> ;Plos One. 2014 Jul 3
• 6 citations
  Editorial Commentary: Is the Debate About Treatment of Candida parapsilosis Complex Infections With Echinocandins Much Ado About Nothing?
  Annette C. Reboli> ;Clinical Infectious Diseases. 2014 May 15
• 113 citations
  MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in ...
  Luis Ostrosky-Zeichner, Shmuel Shoham, Jose A. Vazquez, Annette C. Reboli, Robert F. Betts, Michelle A. Barron, Mindy G. Schuster, Marc A. Judson, Sanjay G. Revankar, ...> ;Clinical Infectious Diseases. 2014 May 1
• 20 citations
  Micafungin: an evidence-based review of its place in therapy
  Pola de la Torre, Annette C. Reboli> ;Core Evidence. 2014 Feb 25
• 66 citations
  Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis:...
  Jose A. Vazquez, Annette C. Reboli, Peter G. Pappas, Thomas F. Patterson, John F. Reinhardt, Peter Chin-Hong, Ellis H. Tobin, Daniel H. Kett, Pinaki Biswas, Robert N. ...> ;BMC Infectious Diseases. 2014 Feb 21
• 18 citations
  Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry
  Dionissios Neofytos, Shirish Huprikar, Annette C. Reboli, Mindy G. Schuster, Nkechi Azie, Billy Franks, David Horn> ;European Journal of Clinical Microbiology & Infectious Diseases. 2014 Jan 1
• 36 citations
  Prevention of central venous catheter-related bloodstream infections: is it time to add simulation training to the prevention bundle?
  Amanda R. Burden, Marc C. Torjman, George E. Dy, Jonathan Douglas Jaffe, Jeffrey J. Littman, Fiorella Nawar, S. Sujanthy Rajaram, Christa Schorr, Gregory W. Staman, An...> ;Journal of Clinical Anesthesia. 2012 Nov 1
• 530 citations
  Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials
  David R. Andes, Nasia Safdar, John W. Baddley, Geoffrey Playford, Annette C. Reboli, John H. Rex, Jack D. Sobel, Peter G. Pappas, Bart Jan Kullberg> ;Clinical Infectious Diseases. 2012 Mar 12
• 11 citations
  Anidulafungin: when and how? The clinician’s view
  Jomy M. George, Annette C. Reboli> ;Mycoses. 2012 Jan 1
• 74 citations
  Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guideline...
  Daniel H. Kett, Andrew F. Shorr, Annette C. Reboli, Arlene Reisman, Pinaki Biswas, Haran T. Schlamm> ;Critical Care. 2011 Oct 25
• 67 citations
  Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: A multivariate analysis of fact...
  Annette C. Reboli, Andrew F. Shorr, Coleman Rotstein, Peter G. Pappas, Daniel H. Kett, Haran T. Schlamm, Arlene Reisman, Pinaki Biswas, Thomas J. Walsh> ;BMC Infectious Diseases. 2011 Sep 30
• 19 citations
  Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients.
  Annette C. Reboli, Coleman Rotstein, Daniel H. Kett, Michael Maschio, Shannon Cartier, Richard Chambers, M. Tarallo> ;Pharmacoeconomics. 2011 Aug 1
• 81 citations
  Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit.
  Luis Ostrosky-Zeichner, Peter G. Pappas, Shmuel Shoham, Annette C. Reboli, Michelle A. Barron, Charles R. Sims, Craig A. Wood, Jack D. Sobel> ;Mycoses. 2011 Jan 1
• 2182 citations
  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
  Peter G. Pappas, Carol A. Kauffman, David R. Andes, Daniel K. Benjamin, Thierry Calandra, John E. Edwards, Scott G. Filler, John F. Fisher, Bart Jan Kullberg, Luis Ost...> ;Clinical Infectious Diseases. 2009 Mar 1
• 7 citations
  Anidulafungin: a novel echinocandin for candida infections.
  Pola de la Torre, Daniel K Meyer, Annette C. Reboli> ;Future Microbiology. 2008 Dec 11
• 8 citations
  Anidulafungin: a drug evaluation of a new echinocandin
  Jomy M Joseph, Rose Kim, Annette C. Reboli> ;Expert Opinion on Pharmacotherapy. 2008 Aug 19
• 27 citations
  A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis.
  Jose A. Vazquez, Jennifer Schranz, Kay Clark, Beth P. Goldstein, Annette C. Reboli, Carl J. Fichtenbaum> ;Journal of Acquired Immune Deficiency Syndromes. 2008 Jul 1
• 449 citations
  Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
  Peter G. Pappas, Coleman Rotstein, Robert F. Betts, Marcio Nucci, Deepak Talwar, Jan J. De Waele, Jose A. Vazquez, Bertrand Dupont, David Horn, Luis Ostrosky-Zeichner,...> ;Clinical Infectious Diseases. 2007 Oct 1
• Join now to see all

Other

• Erysipelothrix infection 
  Reboli AC
  http://www.uptodate.com/contents/erysipelothrix-infection
  UpToDate, Wolters Kluwer Health - 2010-05-18